Human Microbiome Drug Targets

Capture the future of medicine with Human Microbiome Drug Targets, a definitive guide from Genevieve Dable-Tupas, Rohini Karunakaran, Peter Paul C Lim, and Maria Catherine B Otero. Designed for researchers, clinicians, and industry leaders, this book illuminates how the human microbiome is reshaping drug discovery and precision therapeutics worldwide.

Discover clear, evidence-driven chapters that translate complex microbial ecology into practical drug-target strategies. From gut and skin microbiomes to oral and respiratory ecosystems, the authors map microbial pathways, host–microbe interactions, and actionable biomarkers that accelerate translational research. Expect rigorous analysis of target validation, therapeutic modulation techniques, and regulatory considerations—essential reading for anyone working in pharmacology, biotech, or clinical practice.

Why this book matters: it bridges bench science and bedside application, offering multidisciplinary perspectives that resonate across North America, Europe, Asia-Pacific, and emerging markets. Whether you’re developing next-generation antibiotics, microbiome modulators, or personalized treatments, the insights here sharpen decision-making and de-risk development pipelines.

Packed with practical frameworks, clinical implications, and forward-looking commentary, Human Microbiome Drug Targets equips you to harness microbial communities as therapeutic allies. Written in a clear, authoritative voice, it’s both a textbook for graduate students and a strategic resource for senior scientists and healthcare executives.

Advance your understanding—and your projects. Add this essential volume to your library and stay at the forefront of microbiome-driven drug innovation. Order your copy today and lead the next wave of precision medicine.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.